Ontology highlight
ABSTRACT: Background
A consensus prognostic gene expression classifier is still elusive in heterogeneous diseases such as breast cancer.Results
Here we perform a combined analysis of three major breast cancer microarray data sets to hone in on a universally valid prognostic molecular classifier in estrogen receptor (ER) positive tumors. Using a recently developed robust measure of prognostic separation, we further validate the prognostic classifier in three external independent cohorts, confirming the validity of our molecular classifier in a total of 877 ER positive samples. Furthermore, we find that molecular classifiers may not outperform classical prognostic indices but that they can be used in hybrid molecular-pathological classification schemes to improve prognostic separation.Conclusion
The prognostic molecular classifier presented here is the first to be valid in over 877 ER positive breast cancer samples and across three different microarray platforms. Larger multi-institutional studies will be needed to fully determine the added prognostic value of molecular classifiers when combined with standard prognostic factors.
SUBMITTER: Teschendorff AE
PROVIDER: S-EPMC1794561 | biostudies-literature | 2006
REPOSITORIES: biostudies-literature
Teschendorff Andrew E AE Naderi Ali A Barbosa-Morais Nuno L NL Pinder Sarah E SE Ellis Ian O IO Aparicio Sam S Brenton James D JD Caldas Carlos C
Genome biology 20061031 10
<h4>Background</h4>A consensus prognostic gene expression classifier is still elusive in heterogeneous diseases such as breast cancer.<h4>Results</h4>Here we perform a combined analysis of three major breast cancer microarray data sets to hone in on a universally valid prognostic molecular classifier in estrogen receptor (ER) positive tumors. Using a recently developed robust measure of prognostic separation, we further validate the prognostic classifier in three external independent cohorts, co ...[more]